Skip to Main Content

Paper Details

THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.
3
2022
BC, Breast cancer, TERT hypermethylated oncological region, THOR, THOR region, benign tissue, breast cancer, cancer, dCas9, hTERT, hTERT core promoter, hTERT promoter, histologic cancer, human, human telomerase reverse transcriptase, luciferase, malignant breast, malignant tumor, normal tissue, patients, repressive regulatory element, telomerase, telomere, women
Author NameAffiliation
Uri TaboriThe Hospital for Sick Children
Uri TaboriArthur and Sonia Labatt Brain Tumor Research Center, The Hospital for Sick Children, University of Toronto
Uri TaboriThe Hospital for Sick Children
  • 1 - 3

Datasets

Release 1.2